PREVIOUS
✖
VINCOV-19
May 13 , 2021
1101 days
724
0
- VINCOV-19 is Novel antibody engineered product to treat COVID-19 cleared for clinical trials.
- It is a collaborative effort of
- University of Hyderabad (UoH),
- CSIR-Centre for Cellular and
- Molecular Biology (CSIR-CCMB) and Vins Bioproducts Ltd.
- It got approval from the Drugs Controller General of India (DGCI) for clinical trials to test against the COVID-19 pandemic.
Leave a Reply
Your Comment is awaiting moderation.